Många feces-Hb-test till liten nytta

Lakartidningen

Volumn 107, Issue 21, 2010, Pages 1372-1375

  Högberg, Cecilia ^a   Asplund, Ragnar ^a  

^a Brunflo hälsocentral ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CHEMISTRY; COLORECTAL TUMOR; FECES; FEMALE; HEALTH CENTER; HUMAN; IMMUNOCHEMISTRY; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COMMUNITY HEALTH CENTERS; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY;

EID: 77953334121     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nationella riktlinjer för kolorektalcancersjukvård. Medicinskt och hälsoekonomiskt faktadokument. Stockholm: Socialstyrelsen; 2007.
2. Onkologiskt centrum i Umeå. http://www.oc.umu.se
3. Fraser CG. Faecal occult blood tests - eliminate, enhance or update? Ann Clin Biochem. 2008;45: 117-21.
4. Allison JE. Colon cancer screening guidelines 2005: The fecal occult blood test option has become a better FIT. Gastroenterology. 2005;129:745-8.
5. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-71.
6. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occultblood screening for colorectal cancer. Lancet. 1996;348:1472-7.
7. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-71.
8. Oy Medix Biochemica Ab. http://www.medixbiochemica.com
9. Irritable bowel syndrome in adults. Diagnosis and management of irritable bowel syndrome in primary care. NICE clinical guideline 61. National Institute for Health and Clinical Excellence. February 2008. http://www.nice.org.uk
10. Nakama H, Zhang B, Fattah ASMA, Zhang X. Colorectal cancer in iron deficiency anemia with a positive result on immunochemical fecal occult blood. Int J Colorectal Dis. 2000;15:271-4.
11. du Toit J, Hamilton W, Barraclough K. Risk in primary care of colorectal cancer from new onset rectal bleeding: 10 year prospective study. BMJ. 2006;333:69-70.
12. Nørrelund N, Nørrelund H. Colorectal cancer and polyps in patients aged 40 years and over who consult a GP with rectal bleeding. Fam Pract. 1996;13:160-5.
13. Fraser CG, Matthew CM, Mowat NAG, Wilson JA, Carey FA, Steele RJC. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. Lancet Oncol. 2006;7:127-31.
14. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422-8.
15. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007;56:210-4.
16. Zohar L, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244-55.
17. Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med. 2009;150:162-9.